Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelis H van Werkhoven

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Human Vaccines & Immunotherapeutics|December 13, 2016
Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?Cornelis H van Werkhoven
Clinics in Chest Medicine|November 5, 2018
Vaccines to Prevent Pneumococcal Community-Acquired PneumoniaCornelis H van Werkhoven, Susanne M Huijts
Future Microbiology|September 9, 2015
The Community-Acquired Pneumonia immunization Trial in Adults (CAPiTA): what is the future of pneumococcal conjugate vaccination in elderly?Cornelis H van Werkhoven, Marc J M Bonten
Current Opinion in Pulmonary Medicine|February 16, 2017
Community-acquired pneumonia requiring hospitalization: rational decision making and interpretation of guidelinesDouwe F Postma, Cornelis H van Werkhoven, Jan Jelrik Oosterheert
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 22, 2014
Rapid Systematic Review of the Epley Maneuver versus Vestibular Rehabilitation for Benign Paroxysmal Positional VertigoInge Wegner, Marlien E F Niesten, Cornelis H van Werkhoven, et al.
Journal of Clinical Epidemiology|July 22, 2015
The scrutiny of identifying community-acquired pneumonia episodes quantified bias in absolute effect estimation in a population-based pneumococcal vaccination trialCornelis H van Werkhoven, Susanne M Huijts, Fleur P Paling, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Effectiveness of extended- versus normal-release nitrofurantoin for cystitis: an instrumental variable analysisThijs Ten Doesschate, Rolf H H Groenwold, Marc J M Bonten, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2015
The Impact of Age on the Efficacy of 13-valent Pneumococcal Conjugate Vaccine in ElderlyCornelis H van Werkhoven, Susanne M Huijts, Marieke Bolkenbaas, et al.
Vaccine|April 16, 2017
Post-hoc analysis of a randomized controlled trial: Diabetes mellitus modifies the efficacy of the 13-valent pneumococcal conjugate vaccine in elderlySusanne M Huijts, Cornelis H van Werkhoven, Marieke Bolkenbaas, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 24, 2020
Effects of 13-valent pneumococcal conjugate vaccination of adults on lower respiratory tract infections and antibiotic use in primary care: secondary analysis of a double-blind randomized placebo-controlled studyCornelis H van Werkhoven, Marieke Bolkenbaas, Susanne M Huijts, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Human Vaccines & Immunotherapeutics|December 13, 2016
Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?Cornelis H van Werkhoven
Clinics in Chest Medicine|November 5, 2018
Vaccines to Prevent Pneumococcal Community-Acquired PneumoniaCornelis H van Werkhoven, Susanne M Huijts
Future Microbiology|September 9, 2015
The Community-Acquired Pneumonia immunization Trial in Adults (CAPiTA): what is the future of pneumococcal conjugate vaccination in elderly?Cornelis H van Werkhoven, Marc J M Bonten
Current Opinion in Pulmonary Medicine|February 16, 2017
Community-acquired pneumonia requiring hospitalization: rational decision making and interpretation of guidelinesDouwe F Postma, Cornelis H van Werkhoven, Jan Jelrik Oosterheert
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 22, 2014
Rapid Systematic Review of the Epley Maneuver versus Vestibular Rehabilitation for Benign Paroxysmal Positional VertigoInge Wegner, Marlien E F Niesten, Cornelis H van Werkhoven, et al.
Journal of Clinical Epidemiology|July 22, 2015
The scrutiny of identifying community-acquired pneumonia episodes quantified bias in absolute effect estimation in a population-based pneumococcal vaccination trialCornelis H van Werkhoven, Susanne M Huijts, Fleur P Paling, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Effectiveness of extended- versus normal-release nitrofurantoin for cystitis: an instrumental variable analysisThijs Ten Doesschate, Rolf H H Groenwold, Marc J M Bonten, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2015
The Impact of Age on the Efficacy of 13-valent Pneumococcal Conjugate Vaccine in ElderlyCornelis H van Werkhoven, Susanne M Huijts, Marieke Bolkenbaas, et al.
Vaccine|April 16, 2017
Post-hoc analysis of a randomized controlled trial: Diabetes mellitus modifies the efficacy of the 13-valent pneumococcal conjugate vaccine in elderlySusanne M Huijts, Cornelis H van Werkhoven, Marieke Bolkenbaas, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 24, 2020
Effects of 13-valent pneumococcal conjugate vaccination of adults on lower respiratory tract infections and antibiotic use in primary care: secondary analysis of a double-blind randomized placebo-controlled studyCornelis H van Werkhoven, Marieke Bolkenbaas, Susanne M Huijts, et al.
Pageof 7